Literature DB >> 12919432

Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank.

Tokiko Nagamura-Inoue1, Mika Shioya, Michiko Sugo, Yan Cui, Atsuko Takahashi, Satomi Tomita, Yizhou Zheng, Kei Takada, Hideki Kodo, Shigetaka Asano, Tsuneo A Takahashi.   

Abstract

BACKGROUND: Prolonged periods of marrow hypoplasia have been a problem in cord blood transplantation. DMSO is thought to produce osmotic shock to the progenitors when the thawed cells are infused into the patients. To solve this problem, a 2x dilution method originally developed in the New York Blood Center showed earlier myeloid engraftment,1 although follow-up clinical studies have not performed. STUDY DESIGN AND METHODS: To clarify the influence of the removal of DMSO by this method on the speed of engraftment in unrelated cord blood transplantation, 46 adult patients with cord blood units processed by the Tokyo Cord Blood Bank from September 1998 to March 31, 2002 were studied. Twenty-four patients received 2.6 +/- 0.71 x 10(7) nucleated cells per kg without washing (nonwashed group), while 22 patients were received 2.7 +/- 0.52 x 10(7) nucleated cells per kg after 2x dilution washing (washed group).
RESULTS: The cumulative incidence of engraftment was not significantly different between the two groups. Median neutrophil recovery (>/=5 x 10(9)/L) in the nonwashed and washed groups was 26 and 25 days, respectively, and the median platelet recovery (>/=20 x 10(9)/L) in patients with myeloid engraftment was 44 and 40 days, respectively (NS). On the other hand, the doses of CFCs and CD34+ cells showed the influence on myeloid and platelet recovery.
CONCLUSION: A 2x dilution after thawing cord blood did not result in the improvement of myeloid engraftment speed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919432     DOI: 10.1046/j.1537-2995.2003.00486.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation.

Authors:  Shohei Yamamoto; Hirokazu Ikeda; Daisuke Toyama; Mayumi Hayashi; Kousuke Akiyama; Manabu Suzuki; Yutaka Tanaka; Tsuneki Watanabe; Yoko Fujimoto; Ichirou Hosaki; Hirokazu Nishihira; Keiichi Isoyama
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

2.  Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.

Authors:  Masayoshi Minegishi; Tsuneo Itoh; Narumi Fukawa; Tamie Kitaura; Junko Miura; Hiroyuki Takahashi; Akira Suzuki; Yoshinori Kudo; Ayuko Narita; Yuko Sato; Masakuni Suzuki; Takanori Watanabe; Yuichi Wada; Yoichi Takeyama; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

Review 3.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

4.  Quality assessment of umbilical cord blood units at the time of transplantation.

Authors:  Yoshinori Kudo; Masayoshi Minegishi; Osamu Seki; Hiroyuki Takahashi; Akira Suzuki; Ayuko Narita; Yuko Sato; Machiko Abe; Natsuko Ishioka; Hideo Harigae; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

Review 5.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

Review 6.  Umbilical cord blood quality and quantity: Collection up to transplantation.

Authors:  Seyed Hadi Mousavi; Morteza Zarrabi; Saeid Abroun; Mona Ahmadipanah; Bahareh Abbaspanah
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.